Effect of hyperbaric oxygen therapy on cognitive impairment after aneurysm subarachnoid hemorrhage

Abstract

Purpose: To evaluate the effect of hyperbaric oxygen therapy (HBOT) on cognitive impairment after aneurysm subarachnoid hemorrhage (aSAH). Methods: The current study was carried out in a regional neurosurgical center in Taiyuan, Shanxi Province of China from January 2019 to September 2020. A total of 150 patients with persistent cognitive dysfunction at 3 months after aSAH onset were enrolled, which were randomly classified into group A (HBOT) and group B (control) via the random number table method. The outcome was evaluated by Montreal cognitive assessment (MoCA). Results: There were no significant differences between group A and group B with regard to MoCA score and proportions of normal MoCA patients at 3 months after HBOT (p > 0.05). Both groups showed no significant differences in proportions of normal MoCA patients at 6 months after HBOT (p > 0.05). However, there were significant differences between group A and group B with MoCA score of patients at 6 months after HBOT (p < 0.05). There were also significant differences in MoCA score and proportions of normal MoCA patients at 9 months after HBOT. Conclusion: HBOT alleviates cognitive impairment after aSAH, and thus may be used to manage cognitive impairment in patients after aSAH. However, further clinical trials are required prior to application in clinical practice.